Comparison of Mesh Fixation and Non-Fixation in eTEP
Launched by MEHMET EŞREF ULUTAŞ · May 11, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating two different ways to secure a mesh implant during laparoscopic inguinal hernia surgery, known as the extended total extraperitoneal repair (eTEP). The study aims to find out whether fixing the mesh to a specific area (the Cooper's ligament) helps prevent it from moving and reduces the chances of the hernia coming back, while also looking at how this fixation might affect pain and recovery after surgery. Researchers want to see if patients who have mesh fixation experience different outcomes compared to those who do not.
To participate in this trial, you need to be between 18 and 65 years old and have a unilateral (one-sided) inguinal hernia. Unfortunately, those who are younger than 18, older than 65, have complicated hernias, or are pregnant cannot join. Participants will be closely monitored for things like how long they stay in the hospital, any pain they experience, and if the hernia returns after surgery. This study is currently recruiting participants and aims to provide clearer insights into the best practices for hernia repair using the eTEP technique.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with unilateral inguinal hernias,
- • Patients aged 18-65.
- Exclusion Criteria:
- • Younger than 18 years, and older than 65 years,
- • Incarcerated or strangulated inguinal hernias,
- • Patients with bilateral inguinal hernias,
- • Patients who are contraindicated to receive general anesthesia,
- • Pregnancy
About Mehmet Eşref Ulutaş
Mehmet Eşref Ulutaş is a distinguished clinical trial sponsor known for his commitment to advancing medical research and innovation. With a focus on ensuring the highest standards of ethical practice and scientific rigor, he leads initiatives that facilitate the development of novel therapies and treatments. His expertise in clinical trial design and execution has contributed to significant advancements in patient care, making him a pivotal figure in the healthcare research community. Through collaboration with various stakeholders, Ulutaş aims to bridge the gap between scientific discovery and practical application, ultimately enhancing the efficacy and accessibility of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Van, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported